Ferrous bisglycinate vs ferrous sulphate: which to formulate with

If you are specifying an iron product for the Indian market, this is the decision that most affects both your cost and whether your customer finishes the course.

Ferrous sulphate is cheapest and carries the most evidence. Ferrous bisglycinate is gentler and costs several times more.

Written for formulators, and useful to anyone comparing two labels.

This is information, not medical advice. Dose and form for an individual should be set by a doctor after testing. Do not take iron without testing.

Why tolerability is the commercial question

This frames everything below.

A large proportion of people prescribed iron stop taking it, and the reason is almost always gastrointestinal side effects rather than recovery.

Which means: the best-absorbed iron in the world does nothing if the bottle sits unused after two weeks. In this category, tolerability is efficacy, and that is an unusual situation that justifies paying attention to the form.

Where the side effects come from: only a fraction of an oral iron dose is absorbed. The unabsorbed remainder passes through the gut, where it irritates the mucosa directly and alters the gut microbiota. Side effects scale with the unabsorbed amount, so anything that improves the absorbed fraction, or lowers the total load, reduces them.

Ferrous sulphate

What it is: an inorganic iron salt, the long-established standard.

Elemental iron: about 20%, so 325 mg of the salt delivers roughly 65 mg of iron.

Evidence: the most extensive by a wide margin. It is the form used in most clinical trials, in national supplementation programmes, and in WHO guidance. If you want to stand on evidence, this is the form that has it.

Cost: the lowest. Materially so.

Stability and supply: excellent, widely available from many suppliers.

The problem: the most gastrointestinal complaints of the common forms, nausea, constipation, abdominal discomfort, metallic taste. It is the form people mean when they say iron did not agree with them.

Ferrous bisglycinate

What it is: iron chelated to two glycine molecules, an amino acid chelate.

The mechanism, which is the point: the chelate holds the iron in a stable ring structure. This appears to leave less free iron in the gut lumen, which is the plausible explanation for the better tolerance, and it makes absorption less affected by inhibitors such as phytates and polyphenols, relevant in a diet full of both.

Elemental iron: typically around 20%, though this varies by grade, check the specification rather than assuming.

Evidence: a smaller body than sulphate, with several comparative studies reporting better bioavailability and notably fewer gastrointestinal side effects. The trials are generally smaller and some are industry-funded, and the tolerability finding is consistent enough to be credible and is the common clinical experience.

And a practical consequence of better absorption: lower elemental doses are often used, which further reduces the gut load, a compounding benefit.

Cost: several times higher than sulphate.

Supply: narrower, with recognised branded grades costing more.

Side by side

	Ferrous sulphate	Ferrous bisglycinate
Type	Inorganic salt	Amino acid chelate
Elemental iron	~20%	~20% (verify the grade)
Evidence base	Extensive, trials, programmes, WHO	Moderate, consistent on tolerability
Bioavailability	Standard reference	Reported better
GI side effects	Most	Notably fewer
Affected by phytates/polyphenols	Yes, substantially	Less
Cost	Lowest	Several times higher
Usable dose	Standard	Often lower for same effect
Supply breadth	Wide	Narrower
Taste in liquids	Metallic, astringent	Better
Adherence in practice	Poorer	Better

The arithmetic that actually decides it

This is the part most formulators get wrong, and it changes the cost comparison.

The naive comparison: bisglycinate costs several times more per kilogram, therefore the product costs several times more. That is wrong.

Why:

First, iron is a small part of the formulation cost. At a few tens of milligrams per unit, the iron salt is rarely the dominant line item, capsule, excipients, packaging, testing and overhead usually exceed it.

Second, you may use less. If better absorption permits a lower elemental dose, the quantity difference partly offsets the price difference.

Third, and the one nobody prices: returns and abandonment. A customer who stops at week two does not reorder, and in a condition requiring three to six months of treatment, the lifetime value of a tolerated product is substantially higher than a cheaper one that gets abandoned.

So do the arithmetic properly: cost per unit including everything, against expected course completion. In our experience bisglycinate usually wins that calculation for a retail D2C brand, and sulphate usually wins for a price-sensitive institutional or mass-market product.

Which to choose

Ferrous sulphate when:

• Price point is the constraint, mass market, government or institutional supply
• You want to align with programme and trial evidence
• A liquid or paediatric product where the lowest cost matters and taste can be masked
• Volume is large and margins thin

Ferrous bisglycinate when:

• The customer has already failed on sulphate, this is the clearest case
• D2C or premium retail, where adherence and reviews drive repeat purchase
• A multi-ingredient formulation where gut tolerance matters because several actives are present
• Pregnancy and lactation products, where nausea is already a problem and iron makes it worse
• Paediatric, where taste and tolerance determine whether the dose is actually given
• A vegetarian-diet market, because reduced inhibitor sensitivity matters more there

The other forms, briefly

Ferrous fumarate, about 33% elemental iron, so fewer tablets. Tolerability similar to sulphate.

Ferrous gluconate, about 12% elemental iron. Its gentler reputation comes substantially from the lower iron per tablet rather than the salt itself, which is worth knowing.

Iron polymaltose complex, gentle, and trial results on efficacy have been mixed, with some studies finding slower haemoglobin correction. Tolerability is good; the efficacy data is less convincing.

Carbonyl iron, slow absorption, lower toxicity in overdose (relevant where children are in the house), takes longer to correct.

Sucrosomial iron, newer, encapsulated, encouraging early tolerability data, small evidence base, expensive.

What to specify on the label

And this is where most Indian iron labels are inadequate.

1. Elemental iron, stated explicitly.

This is the most common and most consequential labelling failure. “Ferrous sulphate 325 mg” and “elemental iron 65 mg” describe the same thing, and a customer cannot compare two products unless both state elemental iron.

State both, and make elemental iron prominent.

2. The form, by name. Sulphate, bisglycinate, fumarate. Not “iron”.

3. Vitamin C, with its quantity. It markedly improves non-haem iron absorption, which is why it belongs in an iron formulation, and the quantity should be declared, not implied.

4. Folic acid and B12 where included, with quantities.

5. The dosing instruction, and this is where you can genuinely help the customer:

• With vitamin C
• At least an hour from tea, coffee and milk
• Away from calcium
• Four hours from thyroid medication
• And expect black stools, harmless, and alarming to anyone not warned

6. And ask about alternate-day dosing. Studies have found alternate-day single dosing gives better fractional absorption and fewer side effects than daily split dosing, because a dose raises hepcidin and blunts absorption for roughly a day. A product designed around that is a genuine differentiator, and almost nobody in this market has done it.

Claims

What is sayable: iron’s recognised role in normal red blood cell and haemoglobin formation, in normal oxygen transport, and in the reduction of tiredness and fatigue; vitamin C’s role in increasing iron absorption; folate and B12’s recognised roles.

These are established nutrient-function claims and they are sufficient. This is one category where the permitted claims genuinely describe what the product does.

What is not sayable: treats anaemia, cures iron deficiency, raises haemoglobin, or treats fatigue as a condition. Anaemia is a diagnosed condition.

And two lines we require on artwork:

Test before taking iron, because iron overload is harmful and some people carry haemochromatosis unknowingly.

And iron deficiency in an adult man or post-menopausal woman needs the cause investigated. This is the most important sentence on an iron pack and it is almost never printed, because in those groups the default assumption is gastrointestinal blood loss, and iron without investigation is how ulcers and bowel cancers get missed.

Our own practice

We specify bisglycinate for our retail women’s health products, on the reasoning above, tolerability determines completion, and completion determines outcome.

We will formulate with sulphate where a client’s price point requires it, and we say plainly that the trade is tolerability.

We declare elemental iron prominently, and we include vitamin C with a stated quantity.

And what we decline: a product whose label states only the salt weight, leaving the customer unable to compare it with anything. That is not a compliance failure so much as a transparency one, and it is standard practice in this category.

The short version

1. Tolerability is efficacy here, a large proportion of people abandon iron because of side effects, and an abandoned course treats nothing.
2. Side effects scale with unabsorbed iron, so better absorption means fewer of them.
3. Ferrous sulphate: cheapest, most evidence, most side effects. ~20% elemental.
4. Ferrous bisglycinate: chelated, notably better tolerated, less affected by phytates and polyphenols, several times the price.
5. The cost comparison is not the raw material ratio, iron is a small part of unit cost, you may use less, and an abandoned course has no value.
6. Choose bisglycinate for D2C, pregnancy, paediatric, vegetarian markets, and anyone who failed on sulphate.
7. Choose sulphate for mass-market and institutional supply, and to stand on programme evidence.
8. Ferrous gluconate’s gentler reputation is partly just less iron per tablet.
9. Iron polymaltose is gentle with mixed efficacy data.
10. State elemental iron prominently. Without it a customer cannot compare two labels.
11. Include vitamin C with its quantity.
12. Print the dosing gaps, tea, calcium, thyroid medication, and warn about black stools.
13. Consider designing for alternate-day dosing. Better absorbed, better tolerated, and nobody here has done it.
14. Require the two warnings: test first, and investigate the cause in men and post-menopausal women.

Composition detail: Femino 360 and Folico 360. Related: iron supplements that do not cause constipation and how to read a manufacturer’s quotation.